AzTrials
AzTrials

Motoric Cognitive Risk SyndromeNCT07572942

Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

An observational study of Motoric Cognitive Risk Syndrome and Cognitive-Motor Interaction, run by Balikesir University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the validity and reliability of neuroscience-based visual laser feedback map tests in individuals with Motoric Cognitive Risk Syndrome (MCRS). The developed assessment protocol integrates visuospatial processing, reaction time, and upper extremity motor control within a single task. Read more about this study

Who is it for?
Ages 65 years and older
How many people
35 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Apr 2026to 15 Jul 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Community-dwelling older adults aged 65 years and above diagnosed with Motoric Cognitive Risk Syndrome will be recruited from the Tazelenme University Coordination Unit in Balıkesir, Turkey. The study population represents individuals at risk of cognitive decline but without diagnosed dementia, enabling the evaluation of early-stage cognitive-motor interaction.

Who may be able to join

  • Aged ≥65 years Diagnosis of Motoric Cognitive Risk Syndrome (subjective cognitive complaint + slow gait) Living independently in the community Able to understand and perform test procedures

Who cannot join

  • Diagnosed dementia Severe psychiatric disorders Advanced visual impairments (e.g., macular degeneration, severe cataract) Neurological disorders affecting motor control Severe tremor or ataxia interfering with task performance

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ebru Tekin, Lecturer contact

+90 266 614 69 11

ebrutekin123@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Balikesir University

    Balıkesir, Bigadiç

    Ebru Tekin, +90 266 614 69 11, ebrutekin123@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Validity and Reliability of Neuroscience-Based Visual Laser Feedback Map Tests in Individuals With Motoric Cognitive Risk Syndrome

This study aims to evaluate the validity and reliability of neuroscience-based visual laser feedback map tests in individuals with Motoric Cognitive Risk Syndrome (MCRS). The developed assessment protocol integrates visuospatial processing, reaction time, and upper extremity motor control within a single task. Construct validity will be examined through correlations with reaction time and proprioception measurements, and test-retest reliability will be assessed to determine measurement consistency.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07572942
Study groupRoleWhat they receive
Motoric Cognitive Risk Syndrome GroupCommunity-dwelling older adults aged 65 years and above diagnosed with Motoric Cognitive Risk Syndrome (MCRS) will be included. Participants will undergo neuroscience-based visual-laser feedback map tests along with reaction time and proprioception assessments under standardized conditions. No therapeutic intervention will be applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual-laser feedback map test performance

    Performance parameters including completion time (seconds), reaction time (milliseconds), movement accuracy, and total performance score obtained from the figure-of-eight tracing and directional target tracking tasks.

    Measured: Baseline

Secondary outcomes (4)
  1. Reaction time

    Reaction time will be assessed using the Light Trainer system. The response time to visual stimuli will be recorded in milliseconds.

    Measured: Baseline

  2. Shoulder proprioception

    Shoulder joint position sense will be assessed using the joint repositioning test. Absolute error will be recorded in degrees.

    Measured: Baseline

  3. Test-retest reliability

    Test-retest reliability of the visual-laser feedback map tests will be evaluated using the Intraclass Correlation Coefficient (ICC).

    Measured: Baseline and 7-day follow-up

  4. Measurement error

    Measurement error will be calculated using the Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC).

    Measured: Baseline and 7-day follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2026
  2. Study start15 Apr 2026
  3. Primary completion28 Apr 2026
  4. Study completion15 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07572942
Sponsor's protocol ID
2026/47
Status last verified
May 2026
First submitted
1 May 2026
Last updated
7 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Pinzón-Ríos, I. D., & Moreno-Collazos, J. E. (2020). Neural aging, brain plasticity and exercise: Advances from a physiotherapy perspective. Archivos de Medicina (Manizales), 20(1), 188-202.

  • Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31.

    PubMed 27330520
  • Shadmehr R, Krakauer JW. A computational neuroanatomy for motor control. Exp Brain Res. 2008 Mar;185(3):359-81. doi: 10.1007/s00221-008-1280-5. Epub 2008 Feb 5.

    PubMed 18251019
  • Moinuddin A, Goel A, Sethi Y. The Role of Augmented Feedback on Motor Learning: A Systematic Review. Cureus. 2021 Nov 18;13(11):e19695. doi: 10.7759/cureus.19695. eCollection 2021 Nov.

    PubMed 34976475
  • Clark DJ. Automaticity of walking: functional significance, mechanisms, measurement and rehabilitation strategies. Front Hum Neurosci. 2015 May 5;9:246. doi: 10.3389/fnhum.2015.00246. eCollection 2015.

    PubMed 25999838
  • Seidler RD, Bernard JA, Burutolu TB, Fling BW, Gordon MT, Gwin JT, Kwak Y, Lipps DB. Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neurosci Biobehav Rev. 2010 Apr;34(5):721-33. doi: 10.1016/j.neubiorev.2009.10.005. Epub 2009 Oct 20.

    PubMed 19850077

Questions about this trial

What is this clinical trial studying?

An observational study of Motoric Cognitive Risk Syndrome and Cognitive-Motor Interaction, run by Balikesir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ebru Tekin, Lecturer (+90 266 614 69 11, ebrutekin123@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual-laser feedback map test performance (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07572942, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in